L-Lactic Acid

L-Lactic Acid

SCHEMBL671982

CC(O)C(=O)[O-].CC(O)C(=O)[O-].CC(O)C(=O)[O-].CC(O)C(=O)[O-].CC(O)C(=O)[O-].CC(O)C(=O)[O-].[Mo+6]

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3

The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.50
CA1 P00915 4/20 0.40
CA4 P22748 3/20 0.38
CA2 P00918 1/20 0.38
CYP3A4 P08684 2/20 0.36
TSHR P16473 2/20 0.36
NFKB1 P19838 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Lactic Acid SCHEMBL5825765 0.92 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL7515818 0.92 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL3767829 0.92 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL16395515 0.92 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL975525 0.92 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL7999572 0.92 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL7469336 0.92 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL21815670 0.92 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL22341771 0.92 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL274590 0.92 TP53 (0.50) TP53CA1CA4CA2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112175011-B Continuous preparation method of homogeneous organic molybdenum compound 中国石油化工股份有限公司 2022-09-27 CN claimed
CN-112920142-B Preparation method of styrene oxide 万华化学集团股份有限公司 2022-09-16 CN claimed
EP-2890829-B1 ZIRCONIUM PRETREATMENT COMPOSITIONS CONTAINING LITHIUM, ASSOCIATED METHODS FOR TREATING METAL SUBSTRATES, AND RELATED COATED METAL SUBSTRATES PPG IND OHIO INC (US) 2022-07-27 EP claimed
CN-112920142-A Preparation method of styrene oxide 万华化学集团股份有限公司 2021-06-08 CN claimed
CN-112175011-A Continuous preparation method of homogeneous organic molybdenum compound 中国石油化工股份有限公司 2021-01-05 CN claimed
US-10400337-B2 Zirconium pretreatment compositions containing lithium, associated methods for treating metal substrates, and related coated metal substrates PPG INDUSTRIES OHIO, INC. (US) 2019-09-03 US claimed
US-10125424-B2 Zirconium pretreatment compositions containing molybdenum, associated methods for treating metal substrates, and related coated metal substrates PPG INDUSTRIES OHIO, INC. (US) 2018-11-13 US claimed
EP-2890830-B1 ZIRCONIUM PRETREATMENT COMPOSITIONS CONTAINING MOLYBDENUM, ASSOCIATED METHODS FOR TREATING METAL SUBSTRATES, AND RELATED COATED METAL SUBSTRATES PPG IND OHIO INC (US) 2018-06-27 EP claimed
EP-3293287-A1 ZIRCONIUM PRETREATMENT COMPOSITIONS CONTAINING MOLYBDENUM, ASSOCIATED METHODS FOR TREATING METAL SUBSTRATES, AND RELATED COATED METAL SUBSTRATES PPG Industries Ohio, Inc. (US) 2018-03-14 EP claimed
US-20150232996-A1 ZIRCONIUM PRETREATMENT COMPOSITIONS CONTAINING LITHIUM, ASSOCIATED METHODS FOR TREATING METAL SUBSTRATES, AND RELATED COATED METAL SUBSTRATES PPG INDUSTRIES OHIO, INC. 2015-08-20 US claimed
US-20150225855-A1 ZIRCONIUM PRETREATMENT COMPOSITIONS CONTAINING MOLYBDENUM, ASSOCIATED METHODS FOR TREATING METAL SUBSTRATES, AND RELATED COATED METAL SUBSTRATES PPG INDUSTRIES OHIO, INC. (US) 2015-08-13 US claimed
EP-2890830-A1 ZIRCONIUM PRETREATMENT COMPOSITIONS CONTAINING MOLYBDENUM, ASSOCIATED METHODS FOR TREATING METAL SUBSTRATES, AND RELATED COATED METAL SUBSTRATES PPG Industries Ohio, Inc. (US) 2015-07-08 EP claimed
EP-2890829-A1 ZIRCONIUM PRETREATMENT COMPOSITIONS CONTAINING LITHIUM, ASSOCIATED METHODS FOR TREATING METAL SUBSTRATES, AND RELATED COATED METAL SUBSTRATES PPG Industries Ohio, Inc. (US) 2015-07-08 EP claimed
WO-2014035690-A1 ZIRCONIUM PRETREATMENT COMPOSITIONS CONTAINING LITHIUM, ASSOCIATED METHODS FOR TREATING METAL SUBSTRATES, AND RELATED COATED METAL SUBSTRATES PPG INDUSTRIES OHIO, INC. (US) 2014-03-06 WO claimed
WO-2014035691-A1 ZIRCONIUM PRETREATMENT COMPOSITIONS CONTAINING MOLYBDENUM, ASSOCIATED METHODS FOR TREATING METAL SUBSTRATES, AND RELATED COATED METAL SUBSTRATES PPG INDUSTRIES OHIO, INC. (US) 2014-03-06 WO claimed
US-12624224-B2 Systems for treating a metal substrate PPG INDUSTRIES OHIO, INC. (US) 2026-05-12 US disclosed
US-20260124642-A1 SYSTEMS AND METHODS FOR TREATING A SUBSTRATE PPG INDUSTRIES OHIO, INC. (US) 2026-05-07 US disclosed
US-6303692-B1 PROVIDING MIXTURE OF RUBBER CEMENT AND 1,3-BUTADIENE; POLYMERIZING INTO SYNDIOTACTIC 1,2-POLYBUTADIENE BY USING CATALYST FORMULATION COMPRISING MOLYBDENUM COMPOUND, HYDROGEN PHOSPHITE COMPOUND AND ORGANOALUMINUM COMPOUND BRIDGESTONE CORPORATION (JP) 2001-10-16 US disclosed
WO-2000075201-A1 MOLYBDENUM-BASED CATALYST COMPOSITION FOR POLYMERIZING CONJUGATED DIENES BRIDGESTONE CORPORATION (JP) 2000-12-14 WO disclosed
US-4450059-A IN THE ABSENCE OF A PHOTOSENSITIZING AGENT THE STANDARD OIL COMPANY (US) 1984-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260124642-A1 SYSTEMS AND METHODS FOR TREATING A SUBSTRATE PLA2G12B, PLA2G2D, SOD1 TP53 2195/4885CA1 123/4885CA4 161/4885
US-12624224-B2 Systems for treating a metal substrate CHRM1, DNMT3B, ITGA4 TP53 2927/4885CA1 332/4885CA4 812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.